-
2023.06
- Commission as a Technical Advisor (Larry W.Kwak)
-
2023.03
- MOU with Genemedicine Co., Ltd.
-
-
2022.11
- Received a venture company certification
-
2022.06
- SAB commission
(3 professors: Seoul National University College of Medicine)
- Received an authorization for corporate -
affilated research & development (R&D) center
-
2022.04
-
2022.03
-
2022.02
- with EYEGENE Co., Ltd.
mRNA Delivery Platform 'EG-R' License In
- Bridge Investment (BMI Korea, Eyegene)
- Angel Investment
-
-
2021.12
- Founding of Renhaim Inc. (Eyegene Spin-off)
-
2021.02
- mRNA platform advancement TF composition
(EYEGENE Co., Ltd.)
-
